NCT07209891

COMPARISON STUY OF KINESIOTAPE AND LOW-LEVEL LASER THERAPY ON HYPERTROPHIC SCAR

Completed NA Last updated 7 October 2025

What this trial tests

NA trial testing Kinesio Tape in Hypertrophic Scar in 60 participants. Completed in 30 December 2024.

Timeline

5 October 2023

Primary endpoint
12 December 2024

30 December 2024

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	5 October 2023
Primary completion	12 December 2024
Estimated completion	30 December 2024
Sites	1 location across Egypt

Drugs / interventions tested

• Kinesio Tape
• Low-Level Laser Therapy (LLLT), 905-nm pulsed Ga-As
• Standardized Scar Care (concomitant for all arms)

Conditions studied

• Hypertrophic Scar — all drugs for Hypertrophic Scar →
• Burn Scar (Post-burn) — all drugs for Burn Scar (Post-burn) →
• Burns — all drugs for Burns →

Sponsor

Cairo University

Who can join

Adults 20 to 45, any sex, with Hypertrophic Scar or Burn Scar (Post-burn). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypertrophic scars after burn injury often cause pain, stiffness, and cosmetic concerns. Kinesio taping (KT) and low-level laser therapy (LLLT; photobiomodulation) are widely used, yet direct comparisons and combined-therapy data remain limited. This single-center, three-arm, parallel randomized controlled trial will compare KT alone, LLLT alone, and their combination in patients with post-burn hypertrophic scars. Sixty participants will be randomized (1:1:1) to receive KT (reapplied every 2-3 days), LLLT using a 905-nm pulsed device (three sessions per week), or KT+LLLT for 8 weeks; all groups receive standardized scar care. Outcome assessors will be blinded. The primary outcome is change in scar pliability/firmness measured with a modified Schiotz tonometer from baseline to week 8. Secondary outcomes include change in pain intensity on a 10-cm visual analogue scale and treatment-related adverse events; an optional assessment at week 12 will evaluate durability. We hypothesize that KT+LLLT will produce greater improvements in elasticity and pain than either modality alone. The trial will be conducted at the Faculty of Physical Therapy, Cairo University (Giza, Egypt). Sponsor: Cairo University; Collaborators: National Institute of Laser Enhanced Sciences (NILES) and Faculty of Physical Therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.